OnMed
Pioneering Electrochemotherapy for Advanced Cancer Treatment (Electroporation Therapies)
Electrochemotherapy (ECT) is a breakthrough localized cancer treatment that significantly enhances drug uptake in tumor cells through short, high-voltage electrical pulses. This clinically proven method improves the effectiveness of chemotherapy agents, leading to higher tumor response rates with minimal side effects.
Fast and minimally invasive:
• The procedure takes only 20–30 minutes and is performed with local anesthesia or mild sedation, ensuring patient comfort.
Versatile combination therapy:
• Electrochemotherapy can be effectively combined with chemotherapy, radiotherapy, surgery, and immunotherapy (IL-12) for enhanced tumor control and better treatment outcomes.
Safe and well-tolerated:
• Adheres to international clinical guidelines, ensuring high patient safety with mild and minimal side effects compared to conventional cancer treatments.
Accelerated healing and recovery:
• Patients experience reduced pain, bleeding, secretions, and inflammation within 48 hours, leading to improved local control of tumoral lesions and the quality of life.
Effective tumor regression:
• Noticeable tumor shrinkage typically occurs within 2 to 4 weeks, offering a rapid and measurable response to treatment.
High response rates across multiple cancer types:
• Electrochemotherapy is effective for a wide range of primary and metastatic tumors, including cutaneous, subcutaneous, and even deep-seated malignancies, offering a promising alternative to conventional therapies.
At OnMed, we are committed to delivering the latest advancements in electroporation therapies to improve treatment outcomes with precision, safety, and efficiency.
